For previous Australia New Zealand Glaucoma Society conference (ANZGS) meetings I have enjoyed jetting off to Brisbane for a couple of days to be immersed in the humidity of Queensland in February. This year, I swapped educating myself sitting in the air-conditioned ballroom of some fancy Queensland
Your high-prescription patients need a little extra TLC. After all, some may have had a long (and scarring!) history of choosing frames to hide those scarily thick lenses without much success. But
In my first article in February, I explained that while accessibility is the right thing to do, it is also the smart thing to do – embracing accessibility provides an opportunity to grow your business through tapping into what we at Be.Lab call ‘the access market’. Here, I look at ways to make simpl
Ocular melanoma (OM) is the most common cancer in the adult eye. OM affects structures in the eye containing melanocytes: the choroid, ciliary body, iris (collectively called the uvea) and the
The RANZCO Practice Managers’ Conference was the first full online conference I have attended, so I was a little dubious about how it would go. Traveling to Brisbane for a long weekend and networking with likeminded people sounded so much more appealing than giving up a weekend to sit at home with a
Non-melanoma skin cancers (NMSCs) are the commonest cancers in Australia and New Zealand. In 2006, the age-standardised incidence of NMSCs was 406 per 100,000 population in New Zealand1. Treatment of NMSCs represents a significant cost to Australasian healthcare systems1,2 and their incidence is ris
Focusing on dry eye disease (DED), the third Ocular Therapeutics Evening (OTE) finally went ahead after a five-month wait. It’s been a while since we had an in-person meeting, so it was great to see at least the top halves of some familiar faces again! It was also entertaining to see the Covid trace
There is a lot to be grumpy about in our industry.
Having helped develop a new set of 10 internationally recognisable and simplified optotypes to improve visual acuity (VA) checks for young children, vision researcher Dr Lisa Hamm admits to being a little fixated by optotype choice. Here she shares that passion with a short guide to the evolution of
Pseudoexfoliation syndrome (PXF) is important to identify as it carries a significant risk of glaucoma. Once pseudoexfoliative glaucoma develops, it may run an aggressive course requiring close monitoring and intensive treatment to prevent significant visual loss.
As business owners navigated the tumultuous last few years, it would be fair to say that more than a few contemplated selling their business. With the ongoing operating uncertainties, many owners have struggled to keep their eyes on the prize and, understandably, motivation and enthusiasm levels hav
